House OKs bill for experimental drugs for terminal patients


Save Story
Leer en español

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

MONTGOMERY, Ala. (AP) — The Alabama House has passed a bill that would give terminally ill patients the right to try experimental drugs.

The bill would authorize access to drugs that have completed a clinical trial but that haven't been approved for general use by the U.S. Food and Drug Administration. The House passed the legislation in a 97-0 vote Thursday.

Ten-year-old Gabe Griffin inspired the bill.

Griffin has Duchenne muscular dystrophy which causes progressive muscle atrophy and often death by age 25.

Griffin's father Scott Griffin says he hopes Gabe's generation might be the first to survive the disease.

House sponsor Rep. April Weaver says Alabama should do everything it can to remove "red tape" for patients.

Senate sponsor Sen. Cam Ward says the bill represents the type of legislation lawmakers should address.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent U.S. stories

Related topics

U.S.
The Associated Press

    STAY IN THE KNOW

    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast